CLINICAL_TRIALS
trial_result
· 2014-04-09
Clinical Trial Update: RAD001 Plus Carboplatin in Breast Cancer Patients [Phase 2]
Summary
Phase 2 study assessing RAD001 (everolimus) in combination with carboplatin in breast cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-04-09